Results 151 to 158 of about 362 (158)

An overview of current phase 3 radiopharmaceutical therapy clinical trials

Frontiers in Medicine
Nicolas Lepareur
exaly  

Compound Index—Journal of Labelled Compounds and Radiopharmaceuticals 2011/2012 (including selected abstracts from presentations given at the 19th International Symposium on Radiopharmaceutical Sciences as reported in Supplement 1)

Journal of Labelled Compounds and Radiopharmaceuticals, 2012
openaire   +1 more source

Radiopharmaceuticals using Radioactive Compounds in Pharmaceutics and Medicine. Hrsg. von A. Theobald (Ellis Horwood Books in Biological Sciences, Series in Pharmaceutical Technology). Ellis Horwood Lim. Chichester/Engl. Vertrieb: J. Wiley & Sons, Chichester, 184 S., geb. $ 34,95 (ca. 98,60)

Pharmazie in unserer Zeit, 1990
openaire   +1 more source

THE ROLE OF RADIOPHARMACEUTICALS IN THE CENTER FOR NUCLEAR SCIENCE AND TECHNOLOGY OF VIETNAM SUPPORTED BY ROSATOM

X.T. Nguyen, K.V. Frolov, A.A. Trukhin
openaire   +1 more source

In Memoriam: In Memory of Michael G. Stabin, PhD, CHP (1957–2025): Visionary of Radiopharmaceutical Dosimetry, Champion of Alpha-Emitter Therapy, and Advocate for Patient-Centered Science

Cancer Biotherapy and Radiopharmaceuticals
openaire   +1 more source

Abstracts of the 20th International Symposium on Radiopharmaceutical Sciences. May 12-17, 2013. Jeju, South Korea.

Journal of labelled compounds & radiopharmaceuticals, 2013
openaire   +1 more source

Can ChatGPT help patients understand radiopharmaceutical extravasations?

Frontiers in Nuclear Medicine
exaly  

NMB Innovators Series Professor Jon Dilworth: Shining a Light on the Chemistry of Metals Used in Biology, Medicine and Radiochemistry: With this series of editorials, NMB honors the scientists in the radiopharmaceutical sciences domain that have dedicated their career to our field and made substantial contributions.

Nuclear medicine and biology
Jonathan R, Dilworth, Jason S, Lewis, Sofia I, Pascu   +2 more
openaire   +1 more source